BIOMAT Database Logo BIOMAT Database Logo

Treatment of children with familial hypercholesterolaemia. 1975

R J West, and A S Fosbrooke, and J K Lloyd

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002792 Cholestyramine Resin A strongly basic anion exchange resin whose main constituent is polystyrene trimethylbenzylammonium Cl(-) anion. Cholestyramine,Colestyramine,Colestyramin,Cuemid,MK-135,Quantalan,Questran,Cholestyramine Resins,Cholestyramines,Colestyramines,Colestyramins,Cuemids,MK 135,MK135,Quantalans,Questrans,Resin, Cholestyramine,Resins, Cholestyramine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R J West, and A S Fosbrooke, and J K Lloyd
Treatment of children with homozygous familial hypercholesterolaemia.
July 2018, European journal of preventive cardiology,
R J West, and A S Fosbrooke, and J K Lloyd
Treatment with probucol of children with familial hypercholesterolaemia.
January 1988, Acta paediatrica Scandinavica,
R J West, and A S Fosbrooke, and J K Lloyd
Treatment of familial hypercholesterolaemia in children.
March 1970, Lancet (London, England),
R J West, and A S Fosbrooke, and J K Lloyd
Use of cholestyramine in treatment of children with familial hypercholesterolaemia.
May 1973, Archives of disease in childhood,
R J West, and A S Fosbrooke, and J K Lloyd
Early initiation of statin treatment in children with familial hypercholesterolaemia.
June 2015, Current opinion in lipidology,
R J West, and A S Fosbrooke, and J K Lloyd
Problems of long-term treatment in children with familial hypercholesterolaemia.
January 1985, Progress in clinical and biological research,
R J West, and A S Fosbrooke, and J K Lloyd
Familial hypercholesterolaemia in children.
July 1974, Nursing mirror and midwives journal,
R J West, and A S Fosbrooke, and J K Lloyd
Arterial abnormalities in children with familial hypercholesterolaemia.
January 2004, Lancet (London, England),
R J West, and A S Fosbrooke, and J K Lloyd
PCSK9 inhibition in children with familial hypercholesterolaemia.
October 2022, The lancet. Diabetes & endocrinology,
R J West, and A S Fosbrooke, and J K Lloyd
Serum phospholipids in children with familial hypercholesterolaemia.
August 1973, Clinica chimica acta; international journal of clinical chemistry,
Copied contents to your clipboard!